Structure Therapeutics
GPCR
GPCR
121 hedge funds and large institutions have $1.75B invested in Structure Therapeutics in 2023 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% more capital invested
Capital invested by funds: $1.64B → $1.75B (+$105M)
0.27% more ownership
Funds ownership: 30.53% → 30.81% (+0.27%)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
Holders
121
Holding in Top 10
8
Calls
$70.3M
Puts
$24.2M
Top Buyers
| 1 | +$143M | |
| 2 | +$99.6M | |
| 3 | +$54.3M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$47.2M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$34.6M |
Top Sellers
| 1 | -$65.8M | |
| 2 | -$53.3M | |
| 3 | -$38.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$37.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$34M |